November 8, 2019 -- On November 7, Waters Corporation announced that it installed the first-ever Waters Select Series Cyclic IMS (ion mobility spectrometry) mass spectrometer.
Aston University's School of Health and Life Sciences, Milford, Massachusetts, will house this equipment which will be used to support disease and drug discovery research.
Mass spectrometry is a widely used analytical method used by scientists to identify and quantify molecules in a sample and determine their detailed molecular structure. With the new ion mobility spectrometer, ions are separated by size, shape, and charge. The Select Series cyclic IMS enters a new level with a novel compact cyclic devise that allows ions to traverse the cyclic region to achieve ion mobility resolution. Moreover, the technology has the ability to perform ion mobility selection for ion mobility/ion mobility and IMSn experiments.
"The new instrument is one of a relatively recent class of mass spectrometers, incorporating ion mobility, which separate molecules based not only on their mass but also by their shape. This allows us to see what is going on in biology in much more detail, including information we are able to gain from the shape of molecules that will allow us to solve much more complex questions" said Andrew Pitt, Professor of Pharmaceutical Chemistry & Chemical Biology, Aston University.
Combining novel IMS capability with significantly improved mass spectrometry performance and enabling software, this platform allows leading researchers to unlock the potential in scientific discovery.
"Human biology is extraordinarily complex and the SELECT SERIES Cyclic IMS gives research scientists the ability to probe deeper into the chemistry and biology of human disease like never before," said Jim Langridge, Advanced MS Technologies Waters Corporation. "By collaborating with leading researchers like Professor Pitt, we continually advance the science of mass spectrometry, accelerating their research into human health and well-being."